RxDoctor Payments DataLook up a doctor →

Brent Harkrider, MD

Interventional Pain Medicine · New Bern, NCNPI 1669826186

Payments from drug & device makers

$14,422in general payments, 2019–2025

Across 487 payments — averaging $29.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Boston Scientific$2K
  • Si-bone, Inc.$830
  • Stimwave Technologies Incorporated$684
  • AbbVie$530
  • Collegium Pharmaceutical, Inc.$488
  • plus $3K from 37 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic161$6,100
Boston Scientific77$2,348
Si-bone, Inc.11$830
Stimwave Technologies Incorporated4$684
AbbVie(2 entities)33$530
Collegium Pharmaceutical, Inc.23$488
Abbott36$426
Globus Medical9$315
Scilex Pharmaceuticals Inc.12$259
Pfizer17$239
Nalu Medical, Inc.3$213
Nevro Corp.10$209
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$205
Lundbeck LLC10$200
Forte Bio-pharma LLC9$187
Biohaven Pharmaceutical Holding Company Ltd.10$159
Virtus Pharmaceuticals LLC7$130
Valinor Pharma, LLC6$112
Vertos Medical, Inc.3$74
Amgen3$71
Tersera Therapeutics LLC2$59
GRT US Holding, Inc.1$58
Saluda Medical Americas, Inc.3$54
Averitas Pharma Inc.2$51
Biotronik NRO, Inc.2$40
Providence Medical Technology, Inc.1$35
Arbor Pharmaceuticals, Inc.2$35
Azurity Pharmaceuticals, Inc.2$33
Lilly USA, LLC2$31
Biohaven Pharmaceuticals, Inc.2$28
Medline Industries LP1$25
Bioventus LLC1$24
Stryker1$20
Merz Pharmaceuticals, LLC1$19
SPR Therapeutics, Inc1$17
Avanos Medical1$16
Painteq LLC1$16
Johnson & Johnson1$15
Vertex1$15
Teva Pharmaceuticals USA, Inc.1$15
International Rehabilitative Sciences, Inc1$14
Kowa Pharmaceuticals America, Inc.1$14
Idorsia Pharmaceuticals US Inc1$13

How this compares

$14,422 in reported general payments places this provider in the 75th percentile of 45 interventional pain medicine providers in North Carolina.

See all interventional pain medicine providers in North Carolina →

Medicare billing

Part B allowed, 2024
$200,131
Medicare patients
354
Services billed
3,160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in New Bern

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →